ChromaDex
Register
Login
ABOUT
About
Science
Contact
Leadership
TRU NIAGEN
Tru Niagen
INGREDIENTS
Ingredients Overview
Niagen
Immulina
Anth Origin
Patents
STANDARDS
Standards
Catalog
Phytochemical Reference Standards
Botanical Reference Materials
Natural Product Libraries
Chemical Family Info
Tech Tips
International
CONSULTING
Consulting
Consulting Food & Dietary Supplements
Consuting Regulatory Support
Pharmaceuticals
Medical Devices
Contract Research Service
Consulting: Spherix Consultant Bios
INVESTOR RELATIONS
NEWS
News
Press Releases
News Events
Investor Relations
>
SEC Filings
About ChromaDex
Presentations & Events
Presentations
Press Releases
Science
SEC Filings
All SEC Filings
Quarterly Results
Annual Reports
Corporate Governance
Charters
Management
Board of Directors
Committee Composition
Code of Conduct
Contact Information
Print Page
E-mail Page
RSS Feeds
E-mail Alerts
View Contacts
SEC Filings
Form 8-K
CHROMADEX CORP. filed this
Form 8-K
on 12/04/2018
Document Outline
Entire Document (2992.9 KB)
Subdocument 1 - 8-K - CURRENT REPORT
Page 1 - UNITED STATES
Page 2 - Item 9.01 Financial Statements and Exhibits.
Page 3 - SIGNATURES
Subdocument 2 - EX-99.1 - PRESENTATION
Page 1 - Exhibit 99.1
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
